The prevalence and risk factors of sexually transmitted infections among correctional institution inmates in Manado, Indonesia
DOI:
https://doi.org/10.66344/jpad.v34i2.2667Keywords:
correctional institution, syphilis, HIV, HBVAbstract
Background Correctional facilities are particularly vulnerable to the spread of sexually transmitted infections (STIs). This study aimed to test for syphilis, human immunodeficiency virus (HIV), and hepatitis B virus (HBV) in inmates at the Correctional Institution Manado, Indonesia, and to evaluate its associated risk factors.
Methods 94 inmates underwent venereal disease research laboratory (VDRL), anti-HIV, and HBsAg testing. Data collection encompassed socio-demographic characteristics, risk factors including age, educational level, marital status, number of sexual partners, sexual orientation, condom usage, intravenous drug use, other drug administration methods, and blood sampling for screening purposes.
Results Sociodemographics were predominantly marked by groups between 25–49 of age (63.8%), possessing an intermediate education (63.9%), married (46.8%), sexually monogamous (54.3%), identifying as heterosexual (95.7%), never using condoms (58.5%), abstaining from intravenous drug use (95.7%), and utilizing other drug types (64.9%). Among the participants, 12.8% tested positive for VDRL, 1.1% for anti-HIV, and 6.4% for HBsAg. Only one subject exhibited reactivity to both VDRL and HBsAg tests. There was a strong connection between marital status and HBsAg (p=0.007).
Conclusion The prison environment offered insights into STI dissemination in a high-risk population, emphasizing that spread prevention needs informative and therapeutic measures.
References
1. World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. [Internet]. 2021 [cited 2023 Jan 21]. Available from: https://www.who.int/publications/i/item/9789240027077
2. World Health Organization. Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. 2022.
3. Dolan K, Wirtz AL, Moazen B, Ndeffo-mbah M, Galvani A, Kinner SA, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. The Lancet. 2016;388;1089–102.
4. UNAIDS. Update on HIV in prisons and other closed settings. Geneva; 2021 Nov.
5. Kouyoumdjian FG, Leto D, John S, Henein H, Bondy S. A systematic review and meta-analysis of the prevalence of chlamydia, gonorrhoea and syphilis in incarcerated persons. Int J STD AIDS. 2012;23(4):248–54.
6. Wirtz AL, Yeh PT, Flath NL, Beyrer C, Dolan K. HIV and Viral Hepatitis among Imprisoned Key Populations. Epidemiol Rev. 2018;40(1):12–26.
7. Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines. MMWR Recomm Rep. 2021;70(RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1.
8. Blogg S, Utomo B, Silitonga N, Hidayati DAN, Sattler G. Indonesian national inmate bio-behavioral survey for HIV and syphilis prevalence and risk behaviors in prisons and detention centers, 2010. Sage Open. 2014;4(1).
9. Nokhodian Z, Yazdani MR, Yaran M, Shoaei P, Mirian M, Ataei B, et al. Prevalence and risk factors of HIV, syphilis, hepatitis B and C among female prisoners in Isfahan. Iran Hepat Mon. 2012;12(7):92–7.
10. Puga MAM, Bandeira LM, Pompilio MA, Rezende GRd, Soares LS, de Castro VdOL. Screening for HBV, HCV, HIV and syphilis infections among bacteriologically confirmed tuberculosis prisoners: An urgent action required. PLoS One. 2019;14(8). Available from: https://doi.org/ 10.1371/journal.pone.0221265
11. Ferreto LED, Guedes S, Pauli FB, Rovani SS, Follador FAC, Vieira AP, et al. Seroprevalence and associated factors of hiv and hepatitis c in brazilian high-security prisons: A state-wide epidemiological study. PLoS One. 2021;16(July).
12. Leite AG da S, Damasceno LM, Conceição SC, Motta PFC. Rapid tests for HIV, syphilis, and chronic hepatitis in a prison population in a prison complex in Salvador (BA), Brazil. Cien Saude Colet. 2022;27(12):4467–74.
13. Wulan Nugrahani N, Udijono A, Dian Saraswati L, Wuryanto Ma. Sexual Behavior at Risk of Sexually Transmitted Infections in Prison : A Descriptive Study at Semarang Class I Penitentiary. J Pub Health Trop Coastal Reg. JPHTCR. 2020;3.
14. Sembiring E, Ginting Y, Saragih RH. Factors associated with syphilis seropositive and Human Immunodeficiency Virus (HIV) infection among inmates at Lubuk Pakam prison, Indonesia. In: IOP Conference Series: Earth and Environmental Science. Institute of Physics Publishing; 2018.
15. Blogg S, Utomo B, Silitonga N, Hidayati DAN, Sattler G. Indonesian national inmate bio-behavioral survey for HIV and syphilis prevalence and risk behaviors in prisons and detention centers, 2010. Sage Open. 2014 Jan 7;4(1).
16. Vieira DS. Prevalence of viral hepatitis B, C and Delta, syphilis and hiv in the prison population in the closed penal system of the western Amazon [Internet]. Available from: http://www.alliedacademies.org/journal-bacteriology-infectious-diseases/ReviewArticle
17. Nayak S, Acharjya B. VDRL test and its interpretation. Indian J Dermatol. 2012;57(1):3–8.
18. Machado F, Becker D, Fernando de Oliveira C, Possuelo LG, Pollo Renner JD. Seroprevalence of HIV, hepatitis B and C and syphilis infection in prisoners of the central region of Rio Grande do Sul, Brazil. Mundo da Saude. 2019;43(1):117–28.
19. Belaunzaran-Zamudio PF, Mosqueda-Gomez JL, MacIas-Hernandez A, Rodríguez-Ramírez S, Sierra-Madero J, Beyrer C. Burden of HIV, Syphilis, and Hepatitis B and C among Inmates in a Prison State System in Mexico. AIDS Res Human Retroviruses. Mary Ann Liebert Inc.; 2017:524–33.
20. Sayyah M, Rahim F, Kayedani GA, Shirbandi K, Saki-Malehi A. Global View of HIV Prevalence in Prisons: A Systematic Review and Meta-Analysis. Iran J Public Health. 2019;48. Available from: http://ijph.tums.ac.ir
21. Horvath A. Biology and Natural History of Syphilis. In: Sexually transmitted diseases and sexually transmitted infections. London: Springer; 2011:129–42.
22. World Health Organization. WHO guidelines for the treatment of treponema pallidum (Syphilis). 51 p.
23. Bautista-Arredondo S, González A, Servan-Mori E, Beynon F, Juarez-Figueroa L, Conde-Glez CJ, et al. A cross-sectional study of prisoners in Mexico city comparing prevalence of transmissible infections and chronic diseases with that in the general population. PLoS One. 2015;10(7).
24. Golrokhi R, Farhoudi B, Taj L, Pahlaviani FG, Mazaheri-Tehrani E, Cossarizza A, et al. HIV Prevalence and Correlations in Prisons in Different Regions of the World: A Review Article. Open AIDS J. 2018;12(1):81–92.
25. Amee Schwitters. Health Intervention for Prisoners. Update of the literature since 2007 [Internet]. Atlanta, USA: World Health Organization; 2014. Available from: http://whqlibdoc.who.int/hiv/pub/idu/prisons_effective/en/
26. Westergaard RP, Spaulding AC, Flanigan TP. HIV among persons incarcerated in the USA: A review of evolving concepts in testing, treatment, and linkage to community care. Curr Opin Infect Dis. 2013;26:10–6.
27. UNAIDS. Update on HIV in Prisons and Other Closed Settings. Geneva, Switzerland; 2021 Nov.
28. Lawan S, Gimba S, Elyuguda A, Sabo H, Dadile HM. Hepatitis B virus infection among prison inmates in Borno State: determination of prevalence of surface antigen )HBsAg) and possible risk factors of disease [Internet]. 2021. Available from: www.austinpublishinggroup.com
29. Bhadoria AS, Gawande KB, Kedarisetty CK, Rewari BB, Pathak VK, Pandey P, et al. Prevalence of Hepatitis B and C Among Prison Inmates in India: A Systematic Review and Meta-Analysis. Cureus. 2021 Nov 17;
30. Nascimento VA do, Mendes RCMG, Macêdo VC de, Frazão CMF de Q, Guedes TG, Linhares FMP. Estratégias para prevenção e controle da sífilis na população privada de liberdade: revisão integrativa. Revista Eletrônica de Enfermagem [Internet]. 2022 Nov 21;24:68811. Available from: https://revistas.ufg.br/fen/article/view/68811
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Nurdjannah Jane Niode, Hessyani Raranta, Diana Shinta Purwanto, Enricco Hendra Mamuaja, Trina Ekawati Tallei
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
